RecruitingNCT07399002

LONG NAGOMI™ PMCF STUDY

Long Coronary Lesions: Safety and Performance of the Ultimaster Nagomi™ Stent in This Setting With a One-to-one Approach -One Lesion, One Stent- LONG NAGOMI™ PMCF STUDY


Sponsor

Fundación EPIC

Enrollment

1,039 participants

Start Date

Feb 27, 2026

Study Type

OBSERVATIONAL

Conditions

Summary

The study is designed as a prospective, multi-center, observational PMCF (post-market clinical follow-up) study of the Ultimaster Nagomi™ \_stent (lengths of 38, 44 and 50 mm) in the treatment of coronary artery disease according to the indications approved in the CE marking.


Eligibility

Min Age: 18 Years

Inclusion Criteria5

  • Patients aged ≥ 18 years AND;
  • Patients who according to standard practice of the hospital are amenable to PCI as indicated and considered adequate according to the European clinical practice guidelines on coronary revascularization AND;
  • Patients with at least one lesion fulfilling the "long lesion criteria" suitable for a single stent approach AND;
  • Patients who have been informed of the characteristics of the study and have provided written informed consent AND;
  • Intention to treat all lesions with the Ultimaster Nagomi™ stent

Exclusion Criteria7

  • Patients who expressly decline to participate in the study.
  • Pregnant or breastfeeding women.
  • Patients with acute coronary syndrome (ACS) under conditions of cardiogenic shock (Killip class 4).
  • Patients with contraindications or hypersensitivity to sirolimus.
  • Patients with a life expectancy of less than 2 years.
  • Patients in whom any surgery requiring general anesthesia is planned, comorbidity or indication likely necessitating the discontinuation of dual anti-platelet therapy before the recommended duration of dual anti-platelet therapy per the ESC or national guidelines.
  • Patients included in other clinical trials that did not reach the primary objective.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICELONG NAGOMI

Patients in whom treatment with long nagomi has been attempted


Locations(4)

Hospital General Universitario de Elche

Elche, Spain

Hospital Universitario de Leon

León, Spain

Hospital Universitario de Navarra

Pamplona, Spain

Hospital Universitario Marqués de Valdecilla

Santander, Spain

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT07399002


Related Trials